Lederlind Mundgel

Nystatin, the active ingredient in Lederlind Mundgel, is a polyene antifungal presented as an oral gel for buccal use. It treats oral candidiasis (thrush) and other mouth infections caused by Candida species. The formulation is designed for direct application to the oral mucosa, providing localized antifungal activity with minimal systemic absorption.

GNH USA supplies Lederlind Mundgel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nystatin is used to treat fungal infections of the oral cavity and related mucosal surfaces.

- Oral candidiasis (thrush): reduces fungal load and alleviates symptoms in patients with Candida overgrowth. - Mouth infections caused by Candida species: controls infection and promotes healing of mucosal lesions. - Denture‑associated stomatitis: helps eradicate Candida on denture surfaces and reduces inflammation.

Adverse reactions may occur with the use of Lederlind Mundgel.

Common Side Effects: - Mild burning sensation in the mouth. - Transient taste alteration. - Mild irritation of oral mucosa.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Oral ulceration. - Systemic absorption leading to hepatic dysfunction (very rare).

Before using Lederlind Mundgel, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to polyene antifungals. - Age considerations: use with caution in infants and young children. - Concurrent oral lesions: avoid application on extensive ulcerated mucosa. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: inform prescriber of concomitant antifungal or systemic medications. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Lederlind Mundgel may interact with other medications; monitor as indicated.

Major Interactions (Avoid): - Concurrent systemic azole antifungals: may reduce the efficacy of Nystatin. - Use with oral antibiotics that disrupt normal flora: may increase risk of fungal overgrowth.

Moderate Interactions (Monitor Closely): - Co‑administration with other topical oral agents: monitor for local irritation. - Use with immunosuppressants: monitor for opportunistic infections. - Concurrent use of oral corticosteroids: may require closer observation.